Cancer leads to muscle loss and compromises organs and cellular functions that can lead to systematic inflammation or edema. InBody’s technology is able to precisely track fluid changes across the body to understand the cause of imbalanced fluid levels.
InBody effectively distinguishes water in the intracellular (ICW; within the tissues) and extracellular (ECW; within the blood and interstitial fluids) compartments that make up total body water (TBW), can be used to distinguish fluid imbalances resulting from malnutrition or edema. Managing increases in Edema index is a priority for improving patient outcomes
Due to the high water content of muscles, loss of muscle mass causes a reduction in ICW and results in an increased Edema Index. Thus the Edema Index can be used to identify malnutrition separately from other disease-related fluid imbalances.
Since cancer symptoms are associated with increased systematic inflammation, progressing fluid imbalances are linked to poor patient outcomes. The Edema Index can be used to identify and monitor long-term fluid retention, which causes cellular stress and may lead to comorbidities such as renal or cardiac dysfunction. By tracking whole body ECW/TBW, efficacy of anti-inflammatory drugs can be assess and used to guide clinical decisions. Additionally, segmental Edema Index scores are important for identifying localized fluid imbalances in the limbs or trunk, aiding in the earlier detection of cancer related lymphedema or circulation issues.